Factors associated with delay in treatment initiation for pulmonary tuberculosis Source: ERJ Open Res, 6 (1) 00161-2019; 10.1183/23120541.00161-2019 Year: 2020
Factors preventing better treatment completion among MDR TB cases in a rich-resource setting Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010
Risk Factors for tuberculosis in patients on anti-TNF treatment Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Factors affecting tuberculosis treatment: the beliefs of patients Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005
Risk factors for paradoxical response during adequate tuberculosis treatment Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005
Risk factors associated with treatment interruption for 2 months among tuberculosis patients in Taipei Source: Annual Congress 2007 - Tuberculosis control Year: 2007
Factors affecting pneumonia treatment outcome Source: Eur Respir J 2005; 26: Suppl. 49, 408s Year: 2005
Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011
Treatment of latent tuberculosis infection: completion rates and adverse effects Source: Eur Respir J 2003; 22: Suppl. 45, 526s Year: 2003
Factors affecting outcomes of individualised treatment for drug resistant tuberculosis in an endemic region> Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017
Predictors of treatment outcome in multidrug-resistant tuberculosis Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011
Factors associated with changing diagnosis of tuberculosis in Taipei Source: Eur Respir J 2006; 28: Suppl. 50, 380s Year: 2006
Factors relevant to bronchostenosis after treatment of endobronchial tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005
Smoking adversely affects treatment response, outcome and relapse in tuberculosis Source: Eur Respir J 2015; 45: 738-745 Year: 2015
Factors influencing initial treatment effect and outcome of pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 478s Year: 2002
Success of re-treatment regime and influencing factors in patients with tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004
Predicting outcomes and drug resistance with standardised treatment of active tuberculosis Source: Eur Respir J 2010; 36: 870-877 Year: 2010
Factors related to response to intermittent treatment of mycobacterium avium complex lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 557s Year: 2006
Risk factors in tuberculosis and its influence on chemotherapy efficiency Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008